Shenzhen Yimi Life Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Yimi Life Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ESPOO. The owner is based in Pingshan, Shenzhen.

302 Bldg C, YouLiTong Sci&Tech Ind. Park

No.56 Qingsong Road, Laokeng, Longtian

Pingshan, Shenzhen 518118 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ESPOO
ESPOO
Registered 2023
ESPOO
ESPOO
Registered 2021

Trademark Classifications

Shenzhen Yimi Life Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Yimi Life Technology Co., Ltd. have?

Shenzhen Yimi Life Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhen Yimi Life Technology Co., Ltd. file in?

Shenzhen Yimi Life Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Shenzhen Yimi Life Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Yimi Life Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as ESPOO. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen Yimi Life Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Yimi Life Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.